𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo

✍ Scribed by Jing Li; Yan Li; Zhi-qiang Feng; Xiao-guang Chen

Book ID
116335144
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
375 KB
Volume
279
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anti-tumor activity of mycophenolate mof
Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo
✍ Robert J. Tressler; Laura J. Garvin; Doris L Slate πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 626 KB

Cultured tumor cell lines, tumor xenografts grown in athymic nude mice, and a murine experimental metastasis model were used to assess the in vitro and in vivo anti-tumor activity of the potent IMP dehydrogenase (IMPDH) inhibitor, mycophenolic acid (MPA), and its morpholinoethyl ester pro-drug, myco

CEP-751 inhibits trk receptor tyrosine k
CEP-751 inhibits trk receptor tyrosine kinase activity in vitro and exhibits anti-tumor activity
✍ Anna Marie Camoratto; Jitesh P. Jani; Thelma S. Angeles; Anna C. Maroney; Christ πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 134 KB πŸ‘ 1 views

The present report describes the in vitro and in vivo profile of CEP-751, a novel receptor tyrosine kinase inhibitor. CEP-751 at 100 nM inhibits the receptor tyrosine kinase activity of the neurotrophin receptors trkA, trkB and trkC. CEP-751 has no effect on activity of receptors for EGF, IGF-I, ins